Skip to content

Insider · CIK 0001816609

Sagar Lonial

director

Files at TGTX (TG THERAPEUTICS, INC.). First filing Nov 12, 2024, latest Sep 12, 2025.

In brief

Sagar Lonial files SEC Form 4 as director at TGTX (TG THERAPEUTICS, INC.). Since Nov 12, 2024, Sagar Lonial has reported 0 open-market buys worth $0 and 2 open-market sells worth $824k, the latest filed on Sep 12, 2025.

A track record needs three past buys with six months of prices behind them; Sagar Lonial has 0, so none is measured yet.

The newest scored trade: sold $672k of TGTX on Sep 11, 2025, filed Sep 12, 2025, scored 40 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $824k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TGTX: TG THERAPEUTICS, INC.

TGTXOct 12, 2026 · close 55.27

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
TGTXsell
TG THERAPEUTICS, INC.
$672k
20,852 shares
-18%+52% from low-29% from high
41Moderate
TGTXsell 3
TG THERAPEUTICS, INC.
$152k
5,000 shares
-5%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Sep 11, 2025 TGTX
TG THERAPEUTICS, INC.
20,852
0.01% of outstanding
$672kSep 11, 2025none
Nov 12, 2024 TGTX
TG THERAPEUTICS, INC.
5,000
0.00% of outstanding
$152kNov 11, 2024none

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 11, 2026TGTX
TG THERAPEUTICS, INC.
AGrant or award
Stock Tracking Unitderivative
+8,325$0.00$08,325Jun 15, 2026
Sep 11, 2025TGTX
TG THERAPEUTICS, INC.
SOpen-market sale
Common Stock
-20,852$32.24$672k94,061Sep 12, 2025
Jun 12, 2025TGTX
TG THERAPEUTICS, INC.
AGrant or award
Common Stock
+14,718$0.00$0114,913Jun 16, 2025
Nov 11, 2024TGTX
TG THERAPEUTICS, INC.
SOpen-market sale
Common Stock
-5,000$30.44$152k100,195Nov 12, 2024

Questions about Sagar Lonial

Answered from the filings on this page, as of the latest one.

Is Sagar Lonial buying or selling?

Not in the last 12 months. Sagar Lonial's latest open-market trade on SEC Form 4 was sold $672k of TGTX on Sep 11, 2025.

How did Sagar Lonial's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sagar Lonial has 0.

Where does Sagar Lonial file Form 4?

Sagar Lonial has filed Form 4 at TGTX (TG THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Sagar Lonial: insider trades and track record | InsiderTell